Home  /  Resource Library  /  Phase II study of dose-adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B-cell lymphoma patients

Phase II study of dose-adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B-cell lymphoma patients

Results of a phase II study investigating chemoimmunotherapy for treatment of relapsed diffuse large b-cell lymphoma in elderly patients.